News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • AtriCure's AtriClip platform could gain widespread adoption if hospitals adopt a new left atrial appendage management quality metric.
  • AtriCure shows improving margins and healthy free cash flow.
  • Analyst recommends a long trade in AtriCure with entry $58.54, stop $50.00, and target $75.00.
  • Bitcoin traded below $76,000, reflecting downward pressure in the crypto market.
  • Binance will close certain European customer accounts by Dec 31 after the EU Markets in Crypto-Assets transition ended.
  • A payments provider disclosed unauthorized access to consumer data, increasing security concerns for crypto users.
  • Lenovo is positioned to benefit from AI hardware demand, with dividend support and recent analyst upgrades.

Latest Articles

FTI Consulting Appoints Eileen Fargis as Senior Managing Director to Enhance Power, Renewables and Energy Transition Advisory Capabilities

FTI Consulting Appoints Eileen Fargis as Senior Managing Director to Enhance Power, Renewables and Energy Transition Advisory Capabilities

FTI Consulting has appointed Eileen Fargis as Senior Managing Director in its global Power, Renewables & Energy Transition practice. With extensive experience in the energy sector, Ms. Fargis will advise clients on strategic, financial, and operational challenges amid growing electricity demand, regulatory changes, and capital constraints. Her appo…

Edible Garden Secures New Walmart Distribution Center Award, Expanding Fresh Herb Distribution in the Upper Midwest

Edible Garden Secures New Walmart Distribution Center Award, Expanding Fresh Herb Distribution in the Upper Midwest

Edible Garden AG Incorporated announced securing an additional Walmart distribution center in the Upper Midwest, expanding its fresh-cut herb business. This award builds on prior expansions and supports the company's strategy for a centralized and scalable distribution network, bolstered by proprietary GreenThumb 2.0 technology and sustainability i…

Zenas BioPharma Announces Upcoming Presentations of Obexelimab Data in IgG4-Related Disease at the IgG4ward! 6th International Symposium on IgG4-Related Disease and ACR Convergence 2026

Zenas BioPharma Announces Upcoming Presentations of Obexelimab Data in IgG4-Related Disease at the IgG4ward! 6th International Symposium on IgG4-Related Disease and ACR Convergence 2026

Zenas BioPharma announced that new Phase 3 clinical data for obexelimab in treating IgG4-related disease will be presented at the 6th International Symposium on IgG4-Related Disease and ACR Convergence 2026. The data includes longer-term efficacy, flare protection, safety, and analyses of glucocorticoid-associated toxicity and vaccine responses. Ob…

OrthoPediatrics Surpasses 1,000 PNP Tibia Nail Implantations

OrthoPediatrics Surpasses 1,000 PNP Tibia Nail Implantations

OrthoPediatrics Corp. announced the implantation of its 1,000th Pediatric Nailing Platform (PNP) Tibia Nail, highlighting rapid adoption of its innovative pediatric-focused tibial nail system. The PNP Tibia System addresses treatment gaps for children with tibia fractures, featuring the only 7mm cannulated rigid tibial nail available, and is curren…

BrewDog Launches ‘Under New Ownership’ Campaign, Marking a New Era of Fresh Energy, New Backing and Award-Winning Beer

BrewDog Launches ‘Under New Ownership’ Campaign, Marking a New Era of Fresh Energy, New Backing and Award-Winning Beer

Tilray Brands, Inc. has initiated a large-scale marketing campaign to promote BrewDog's new era following its acquisition. With a £50 million investment, Tilray aims to re-energize BrewDog’s presence in the UK and Europe, leveraging award-winning beers and expanded product offerings. The campaign includes broad advertising, promotions, and support …

Gogo and Insitu collaborate on Group 3 UAS connectivity

Gogo and Insitu collaborate on Group 3 UAS connectivity

Gogo Special Missions, the military and government division of Gogo Inc., has partnered with Insitu, a Boeing company, to successfully test and integrate a modified high-speed satellite connectivity solution tailored for Group 3 Uncrewed Aerial Systems (UAS). This innovation optimizes the Gogo Galileo HDX antenna for use on Insitu’s Integrator UAS,…

Lexeo Therapeutics Enters Into Agreement to Acquire Mantle Therapeutics and Announces Multiple New Strategic Collaborations to Expand Leadership in Friedreich Ataxia

Lexeo Therapeutics Enters Into Agreement to Acquire Mantle Therapeutics and Announces Multiple New Strategic Collaborations to Expand Leadership in Friedreich Ataxia

Lexeo Therapeutics, a clinical-stage biotech focused on genetic diseases, announced it will acquire Mantle Therapeutics to broaden its Friedreich ataxia (FA) portfolio with multiple new modalities targeting CNS and frataxin restoration. The company also launched three collaborations to explore sequential gene therapy dosing and optimize CNS targeti…

Ligand Acquires Royalty and Milestone Interest in Santen’s Ryjunea® from Sydnexis for $23 Million

Ligand Acquires Royalty and Milestone Interest in Santen’s Ryjunea® from Sydnexis for $23 Million

Ligand Pharmaceuticals has acquired an ascending tiered royalty interest in Ryjunea®, a pharmacological treatment for pediatric myopia approved in Europe, the Middle East, and Africa, from Sydnexis for $23 million upfront. Ligand will receive royalties on Ryjunea net sales and certain milestone payments, accelerating its expansion in ophthalmology …

Plug Power Expands Hydrogen Footprint Across New Zealand and Australia with GenEco™ Electrolyzer Delivery to HWR Hydrogen

Plug Power Expands Hydrogen Footprint Across New Zealand and Australia with GenEco™ Electrolyzer Delivery to HWR Hydrogen

Plug Power announced the shipment and planned installation of a 1 MW GenEco PEM electrolyzer to HWR Hydrogen in Invercargill, New Zealand. This deployment supports the local hydrogen refueling station and HWR's dual-fuel heavy transport fleet, marking a significant step in expanding hydrogen infrastructure in New Zealand and Australia. The company …

Ashland scales Transformed Vegetable Oils technology platform in crop care, launches agrimer™ eco-disperse OD polymeric dispersant

Ashland scales Transformed Vegetable Oils technology platform in crop care, launches agrimer™ eco-disperse OD polymeric dispersant

Ashland Inc. announced the global launch of agrimer™ eco-disperse OD, a new nature-based, biodegradable polymeric dispersant derived from transformed vegetable oil, designed for non-aqueous crop protection formulations. This innovation supports sustainability goals, enhances formulation performance, and addresses regulatory challenges in the crop c…

MediWound Awarded Additional $3.3 Million from U.S. Department of War to Advance Room-Temperature-Stable Formulation of NexoBrid®

MediWound Awarded Additional $3.3 Million from U.S. Department of War to Advance Room-Temperature-Stable Formulation of NexoBrid®

MediWound Ltd. received an additional $3.3 million in non-dilutive funding from the U.S. Department of War to further develop a room-temperature-stable formulation of NexoBrid, enhancing its usability in battlefield burn treatment by simplifying storage and handling. This raises the total program budget for this initiative to $21.8 million, support…

Eledon Presents Updated Long-Term Phase 2 BESTOW Extension Study Results at the International Congress of The Transplantation Society

Eledon Presents Updated Long-Term Phase 2 BESTOW Extension Study Results at the International Congress of The Transplantation Society

Eledon Pharmaceuticals announced that tegoprubart-treated kidney transplant patients demonstrated significantly better kidney function and no acute rejections beyond six months compared to patients treated with tacrolimus, according to updated Phase 2 BESTOW extension study results. The U.S. FDA granted Fast Track designation to tegoprubart for pre…

Celldex Announces Positive Results from Phase 3 EMBARQ-CSU1 and EMBARQ-CSU2 Studies of Barzolvolimab Which Met Primary and All Key Secondary Endpoints

Celldex Announces Positive Results from Phase 3 EMBARQ-CSU1 and EMBARQ-CSU2 Studies of Barzolvolimab Which Met Primary and All Key Secondary Endpoints

Celldex Therapeutics announced that its Phase 3 EMBARQ-CSU1 and EMBARQ-CSU2 trials of barzolvolimab for chronic spontaneous urticaria (CSU) met the primary and all key secondary endpoints at 12 weeks, demonstrating significant, sustained efficacy and a favorable safety profile. The drug showed remarkable benefit in patients refractory to existing t…

AutoZone 4th Quarter Total Company Same Store Sales Increase 1.5%; Domestic Same Store Sales Increase 1.6%; 4th Quarter EPS of $56.05; Annual Sales of $20.3 Billion

AutoZone 4th Quarter Total Company Same Store Sales Increase 1.5%; Domestic Same Store Sales Increase 1.6%; 4th Quarter EPS of $56.05; Annual Sales of $20.3 Billion

AutoZone, Inc. reported a 5.6% increase in net sales for Q4 fiscal 2026 including a 1.6% rise in domestic same store sales. Quarterly EPS grew to $56.05, up from $48.71 last year, driven by tariff refunds, strong gross margins, and operating profit growth of 10.1%. For the full fiscal year, net sales reached $20.3 billion, a 7.4% increase, with dil…

Accelevation Launches Roadshow for Proposed Initial Public Offering

Accelevation Launches Roadshow for Proposed Initial Public Offering

Accelevation Holdings Corp. has announced the launch of its IPO roadshow, proposing to offer 30 million Class A shares priced between $20 and $24 per share and plans to list on Nasdaq under the ticker ACCV. The company intends to use the proceeds primarily to purchase units in its LLC subsidiary for debt repayment, expenses related to the offering,…